103 related articles for article (PubMed ID: 15863917)
1. Tabletting of solid dispersion particles consisting of indomethacin and porous silica particles.
Takeuchi H; Nagira S; Tanimura S; Yamamoto H; Kawashima Y
Chem Pharm Bull (Tokyo); 2005 May; 53(5):487-91. PubMed ID: 15863917
[TBL] [Abstract][Full Text] [Related]
2. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
3. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method.
Takeuchi H; Nagira S; Yamamoto H; Kawashima Y
Int J Pharm; 2005 Apr; 293(1-2):155-64. PubMed ID: 15778053
[TBL] [Abstract][Full Text] [Related]
4. Die wall pressure measurement for evaluation of compaction property of pharmaceutical materials.
Takeuchi H; Nagira S; Yamamoto H; Kawashima Y
Int J Pharm; 2004 Apr; 274(1-2):131-8. PubMed ID: 15072789
[TBL] [Abstract][Full Text] [Related]
5. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
6. Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate).
Takashima Y; Yuasa H; Kanaya Y; Nomura I; Shinozawa K
Int J Pharm; 1999 Sep; 187(1):125-35. PubMed ID: 10502619
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the dissolution rate of a poorly water-soluble drug (tolbutamide) by a spray-drying solvent deposition method and disintegrants.
Takeuchi H; Handa T; Kawashima Y
J Pharm Pharmacol; 1987 Oct; 39(10):769-73. PubMed ID: 2891813
[TBL] [Abstract][Full Text] [Related]
8. A completely solvent-free process for the improvement of erythritol compactibility.
Hoashi Y; Tozuka Y; Takeuchi H
Int J Pharm; 2013 Oct; 455(1-2):132-7. PubMed ID: 23891654
[TBL] [Abstract][Full Text] [Related]
9. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole.
Madgulkar A; Bandivadekar M; Shid T; Rao S
Drug Dev Ind Pharm; 2016 Jan; 42(1):28-38. PubMed ID: 25874729
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
11. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
[TBL] [Abstract][Full Text] [Related]
12. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
13. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant.
Watanabe Y; Koizumi K; Zama Y; Kiriyama M; Matsumoto Y; Matsumoto M
Biol Pharm Bull; 1995 Sep; 18(9):1308-10. PubMed ID: 8845832
[TBL] [Abstract][Full Text] [Related]
14. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
[TBL] [Abstract][Full Text] [Related]
15. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions.
van Drooge DJ; Hinrichs WL; Frijlink HW
J Control Release; 2004 Jul; 97(3):441-52. PubMed ID: 15212876
[TBL] [Abstract][Full Text] [Related]
16. Compression-induced crystallization of amorphous indomethacin in tablets: characterization of spatial heterogeneity by two-dimensional X-ray diffractometry.
Thakral NK; Mohapatra S; Stephenson GA; Suryanarayanan R
Mol Pharm; 2015 Jan; 12(1):253-63. PubMed ID: 25438193
[TBL] [Abstract][Full Text] [Related]
17. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
[TBL] [Abstract][Full Text] [Related]
18. Modeling of latent structure of indomethacin solid dispersion tablet using Bayesian networks.
Hayashi Y; Kikuchi S; Takayama K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1290-7. PubMed ID: 21702729
[TBL] [Abstract][Full Text] [Related]
19. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro evaluation of ibuprofen mouth dissolving tablets using solid dispersion technique.
Jain SK; Shukla M; Shrivastava V
Chem Pharm Bull (Tokyo); 2010 Aug; 58(8):1037-42. PubMed ID: 20686256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
